Yufang Lu

Yufang Lu has accumulated significant work experience in the field of biopharmaceuticals and clinical development. Starting in 1998, Yufang worked as a Scientist in Clinical Safety Dermatology at Procter & Gamble. In 2003, Yufang joined GlaxoSmithKline as a Principle Clinical Scientist in Medical Affairs Dermatology. Yufang then moved to Eisai US in 2006, where they held various positions, including Associate Director, Director, and Senior Director in Clinical Development for Internal Medicine & Immunology. In 2012, Yufang joined Celgene as a Senior Director in Clinical Development, focusing on Immunology. Yufang continued to progress in their career, moving on to Regeneron Pharmaceuticals, Inc. in 2016 as an Executive Director in Medical Affairs Immunology. In 2020, Yufang took on the role of Vice President in Clinical Development Immunology at Celldex Therapeutics before becoming Chief Medical Officer at Inmagene Biopharmaceuticals in 2023.

Yufang Lu completed a Bachelor of Medicine degree in Clinical Training in Dermatology from Nanjing Medical University. Following this, Yufang Lu pursued a Doctor of Philosophy (PhD) in Toxicology with a specialization in Cellular & Molecular Toxicology at Texas A&M University.